Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer

As oxaliplatin results in cumulative neurotoxicity, reducing treatment duration without loss of efficacy would benefit patients and healthcare providers. PATIENTS AND METHODS: Four of the six studies in the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) collaboration included pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Iveson, Timothy J., Sobrero, Alberto F., Yoshino, Takayuki, Souglakos, Ioannis, Ou, Fang-Shu, Meyers, Jeffrey P., Shi, Qian, Grothey, Axel, Saunders, Mark P., Labianca, Roberto, Yamanaka, Takeharu, Boukovinas, Ioannis, Hollander, Niels H., Galli, Fabio, Yamazaki, Kentaro, Georgoulias, Vassilis, Kerr, Rachel, Oki, Eiji, Lonardi, Sara, Harkin, Andrea, Rosati, Gerardo, Paul, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078416/
https://www.ncbi.nlm.nih.gov/pubmed/33439695
http://dx.doi.org/10.1200/JCO.20.01330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078416/
https://www.ncbi.nlm.nih.gov/pubmed/33439695
http://dx.doi.org/10.1200/JCO.20.01330

Ejemplares similares